Last updated: 4 months ago
Kazia Therapeutics' Form 6-K: Key Update on Paxalisib and FDA Engagement
Discover Kazia Therapeutics' latest Form 6-K filing, featuring a crucial update on Paxalisib's regulatory pathway and FDA discussions. Stay informed on their strategic developments.